Regenerx Biopharmaceuticals (RGRX) Total Assets by Year
Regenerx Biopharmaceuticals closed fiscal year 2022 with $382K in total assets, $3.8M in total liabilities and -$3.4M in shareholder equity. This represents a decrease of 70.3% from the prior fiscal year. The table below carries 13 fiscal years, from 2010 to 2022, and the quarters Regenerx Biopharmaceuticals has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
RGRX Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K | FY1010-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $382K-70.3% | $1.3M+132.9% | $552K-22.5% | $712K+153.3% | $281K+23.8% | $227K-73.7% | $862K+140.7% | $358K-62.3% | $949K+2121.4% | $43K-88.0% | $357K-7.0% | $384K-90.9% | $4.2M |
| Total Liabilities | $3.8M+8.9% | $3.5M+4.1% | $3.4M+10.6% | $3.1M+22.4% | $2.5M-42.6% | $4.3M-37.3% | $6.9M-2.4% | $7.1M+166.9% | $2.7M+59.9% | $1.7M+20.6% | $1.4M+70.2% | $811K+31.5% | $617K |
| Total Equity | -$3.4M-54.5% | -$2.2M+21.0% | -$2.8M-20.7% | -$2.3M-5.8% | -$2.2M+46.3% | -$4.1M+32.1% | -$6.1M+10.0% | -$6.7M-293.9% | -$1.7M-5.6% | -$1.6M-58.5% | -$1.0M-139.6% | -$427K-111.8% | $3.6M |
RGRX Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q1'2310-Q | Q4'2210-Q | Q3'2210-Q | Q2'2210-Q | Q1'2210-Q | Q4'2110-K | Q3'2110-Q | Q2'2110-Q | Q1'2110-Q | Q4'2010-K | Q3'2010-Q | Q2'2010-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $187K-80.6% | $382K-70.3% | $581K-63.5% | $736K-65.2% | $961K+204.5% | $1.3M+132.9% | $1.6M+468.4% | $2.1M+328.5% | $315K-53.0% | $552K-22.5% | $280K-71.1% | $493K-61.0% |
| Total Liabilities | $3.9M+11.5% | $3.8M+8.9% | $3.7M+7.5% | $3.6M-1.8% | $3.5M+2.7% | $3.5M+4.1% | $3.5M+6.1% | $3.7M+13.9% | $3.4M+10.6% | $3.4M+10.6% | $3.3M+8.4% | $3.2M+6.5% |
| Total Equity | -$3.7M-45.9% | -$3.4M-54.5% | -$3.1M-68.1% | -$2.9M-84.2% | -$2.6M+17.7% | -$2.2M+21.0% | -$1.9M+37.4% | -$1.6M+43.0% | -$3.1M-28.1% | -$2.8M-20.7% | -$3.0M-46.2% | -$2.7M-55.1% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Regenerx Biopharmaceuticals financials
Frequently Asked Questions
What was Regenerx Biopharmaceuticals's total assets in fiscal year 2022?
Regenerx Biopharmaceuticals closed fiscal year 2022 with $382K in total assets, $3.8M in total liabilities and -$3.4M in shareholder equity.
How fast is Regenerx Biopharmaceuticals's total assets growing?
Regenerx Biopharmaceuticals (RGRX) total assets fell by 70.3% year over year, from $1.3M to $382K in fiscal year 2022.
How has Regenerx Biopharmaceuticals's total assets changed over the years?
Across the 13 fiscal years this page covers, Regenerx Biopharmaceuticals (RGRX) total assets went from $4.2M in fiscal year 2010 to $382K in fiscal year 2022.
What was Regenerx Biopharmaceuticals's total assets in the most recent quarter?
Regenerx Biopharmaceuticals (RGRX) reported $187K in total assets in Q1 2023. This represents a decrease of 80.6% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Regenerx Biopharmaceuticals (RGRX) reported on that line in every period on record.